NVDA · NVIDIA CORP
10-Q filed 2026-05-20 period 2026-04-26
92 Strong
confidence High · source filing on SEC.gov ↗
- NVIDIA is transitioning to a new reporting framework with two market platforms: Data Center (sub-divided into Hyperscale and ACIE) and Edge Computing.
- The Board approved an additional $80.0 billion in share repurchase authorization and increased the quarterly dividend 25-fold from $0.01 to $0.25 per share.
- China's antitrust regulators issued a preliminary finding in September 2025 that NVIDIA's export control compliance violated the terms of the Mellanox acquisition approval.
Filing Health Score pillars
Profitability 25%
98
Revenue grew 85% year-over-year to $81.6 billion, and gross margin expanded to 74.9% from 60.5% in the prior year's quarter due to the non-recurrence of H20 inventory charges (MD&A - First Quarter of Fiscal Year 2027 Summary).
Balance sheet 20%
96
The balance sheet is exceptionally strong with $50.3 billion in cash and marketable debt securities against just $8.5 billion in total debt, and a current ratio of 3.44 (Balance Sheets, Note 9).
Cash generation 20%
95
Operating cash flow reached $50.3 billion, representing excellent cash conversion, with free cash flow of $48.6 billion after $1.8 billion in capital expenditures (Statements of Cash Flows).
Risk flags 20%
75
While financially pristine, the company faces high customer concentration with three customers representing 54% of revenue, and ongoing regulatory risks including China's antitrust inquiry into the Mellanox acquisition terms (MD&A - Concentration of Revenue, Risk Factors).
Mgmt signal 15%
92
Management signaled immense confidence by increasing the quarterly dividend by 25x to $0.25 per share, authorizing an additional $80 billion in share repurchases, and highlighting strong Blackwell momentum (MD&A - Capital Return to Shareholders).
Key metrics (Three Months Ended April 26, 2026)
net income: $58,321 million
cash and equivalents: $13,237 million ($50,335 million including marketable debt securities)
total debt: $8,470 million
shares outstanding: 24,221 million shares (as of April 26, 2026)
revenue: $81,615 million
period: Three Months Ended April 26, 2026
operating cash flow: $50,344 million
Gemma triage notes (pre-analysis, second opinion)
None for this filing.Automated research summaries derived from SEC filings. Not investment advice.